17 results
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
12 Jul 22
Agios Appoints Brian Goff as Chief Executive Officer
4:14pm
,” said Dr. Fouse. “The time is right to evolve our leadership and deepen our genetically defined disease skill set to further drive our ability
DEFA14A
AGIO
Agios Pharmaceuticals Inc
21 Dec 20
Additional proxy soliciting materials
5:21pm
of you who work primarily on our oncology portfolio (or who have skill sets that will help it succeed), will receive an offer of employment from
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
21 Dec 20
Regulation FD Disclosure
7:04am
into mutually beneficial and complementary partnerships where each organization’s skill sets are recognized and leveraged for the benefit of patients.
With our
DEFA14A
EX-99.1
AGIO
Agios Pharmaceuticals Inc
21 Dec 20
Additional proxy soliciting materials
7:10am
into mutually beneficial and complementary partnerships where each organization’s skill sets are recognized and leveraged for the benefit of patients.
With our
S-3ASR
EX-4.4
24t o9zced
30 Apr 20
Automatic shelf registration
4:19pm
S-3ASR
tcsna8s
30 Apr 20
Automatic shelf registration
4:19pm
S-3ASR
EX-4.5
6jij6w4w1
30 Apr 20
Automatic shelf registration
4:19pm
424B5
ft4nmtt18g80swtr3
9 Dec 14
Prospectus supplement for primary offering
12:00am
424B5
e8wq9f
11 Dec 14
Prospectus supplement for primary offering
12:00am
424B5
i47eyf 78j6
6 Nov 19
Prospectus supplement for primary offering
4:07pm
424B5
obah4kde5870 qqz48b
8 Nov 19
Prospectus supplement for primary offering
5:03pm
- Prev
- 1
- Next